Susan E. O’Reilly

2.3k total citations
15 papers, 1.1k citations indexed

About

Susan E. O’Reilly is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Susan E. O’Reilly has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 6 papers in Oncology. Recurrent topics in Susan E. O’Reilly's work include Lymphoma Diagnosis and Treatment (9 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Susan E. O’Reilly is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Susan E. O’Reilly collaborates with scholars based in Canada, United States and United Kingdom. Susan E. O’Reilly's co-authors include Paul Hoskins, Joseph M. Connors, Randy D. Gascoyne, John C. Reed, Anthony W. Tolcher, Caroline Speers, Maryla Krajewska, Stanisław Krajewski, Douglas E. Horsman and Andrew J. Coldman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Susan E. O’Reilly

15 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan E. O’Reilly Canada 12 658 534 234 231 219 15 1.1k
Margaret Shovlin United States 13 639 1.0× 991 1.9× 374 1.6× 262 1.1× 134 0.6× 28 1.3k
M. Jesús Nambo Mexico 17 451 0.7× 544 1.0× 119 0.5× 135 0.6× 139 0.6× 42 896
Brandelyn N. Pitcher United States 19 810 1.2× 587 1.1× 373 1.6× 267 1.2× 219 1.0× 37 1.3k
Simone Ferrero Italy 18 462 0.7× 583 1.1× 270 1.2× 128 0.6× 176 0.8× 82 1.3k
D.J. van Spronsen Netherlands 20 403 0.6× 362 0.7× 83 0.4× 181 0.8× 209 1.0× 36 856
Martin Bast United States 21 584 0.9× 1.0k 1.9× 360 1.5× 104 0.5× 124 0.6× 55 1.2k
Maud Janvier France 20 597 0.9× 382 0.7× 483 2.1× 177 0.8× 119 0.5× 48 1.6k
Jens Ersbøll Denmark 15 381 0.6× 449 0.8× 282 1.2× 91 0.4× 188 0.9× 29 1.1k
Virginie Lucas United States 13 779 1.2× 429 0.8× 119 0.5× 92 0.4× 235 1.1× 24 1.1k
Lucia Nogová Germany 24 683 1.0× 698 1.3× 184 0.8× 154 0.7× 642 2.9× 86 1.5k

Countries citing papers authored by Susan E. O’Reilly

Since Specialization
Citations

This map shows the geographic impact of Susan E. O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. O’Reilly more than expected).

Fields of papers citing papers by Susan E. O’Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. O’Reilly. The network helps show where Susan E. O’Reilly may publish in the future.

Co-authorship network of co-authors of Susan E. O’Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. O’Reilly. A scholar is included among the top collaborators of Susan E. O’Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. O’Reilly. Susan E. O’Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Renouf, Daniel J., Howard J. Lim, Caroline Speers, et al.. (2011). Survival for Metastatic Colorectal Cancer in the Bevacizumab Era: A Population-based Analysis. Clinical Colorectal Cancer. 10(2). 97–101. 24 indexed citations
2.
Pritchard, Kathleen I., Lois E. Shepherd, Judith‐Anne W. Chapman, et al.. (2011). Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14. Journal of Clinical Oncology. 29(29). 3869–3876. 66 indexed citations
3.
Yerushalmi, Rinat, Malcolm Hayes, Karen A. Gelmon, et al.. (2009). A Phase II Trial of a Neoadjuvant Platinum Regimen for Locally Advanced Breast Cancer: Pathologic Response, Long-Term Follow-up, and Correlation With Biomarkers. Clinical Breast Cancer. 9(3). 166–172. 15 indexed citations
4.
McArthur, Heather L., Karen A. Gelmon, Ivo A. Olivotto, et al.. (2009). Effectiveness of a Letter Notification Program for Women With Early-Stage Breast Cancer Eligible for Extended Adjuvant Letrozole. Journal of Clinical Oncology. 27(9). 1388–1393. 3 indexed citations
5.
Chia, Stephen, Caroline Speers, Yulia Dyachkova, et al.. (2007). The impact of new chemotherapeutic and hormone agents on survival in a population‐based cohort of women with metastatic breast cancer. Cancer. 110(5). 973–979. 340 indexed citations
6.
Lemos, Mário L de, et al.. (2006). Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database. Journal of Oncology Pharmacy Practice. 12(4). 193–199. 3 indexed citations
7.
Shenkier, Tamara, Nicholas Voss, Mukesh Chhanabhai, et al.. (2005). The treatment of primary central nervous system lymphoma in 122 immunocompetent patients. Cancer. 103(5). 1008–1017. 30 indexed citations
8.
Shenkier, Tamara, Nicholas Voss, R.N. Fairey, et al.. (2002). Brief Chemotherapy and Involved-Region Irradiation for Limited-Stage Diffuse Large-Cell Lymphoma: An 18-Year Experience From the British Columbia Cancer Agency. Journal of Clinical Oncology. 20(1). 197–204. 29 indexed citations
9.
Macpherson, Nicol, Richard Klasa, Randy D. Gascoyne, et al.. (2002). Treatment of Elderly Hodgkin's Lymphoma Patients with a Novel 5-drug Regimen (ODBEP): A Phase II Study. Leukemia & lymphoma. 43(7). 1395–1402. 26 indexed citations
10.
Connors, Joseph M. & Susan E. O’Reilly. (1997). TREATMENT CONSIDERATIONS IN THE ELDERLY PATIENT WITH LYMPHOMA. Hematology/Oncology Clinics of North America. 11(5). 949–961. 13 indexed citations
11.
O’Reilly, Susan E., Joseph M. Connors, Nicol Macpherson, Richard Klasa, & Paul Hoskins. (1997). Malignant Lymphomas in the Elderly. Clinics in Geriatric Medicine. 13(2). 251–263. 23 indexed citations
12.
Gascoyne, Randy D., Stanisław Krajewski, Maryla Krajewska, et al.. (1997). Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma. Blood. 90(1). 244–251. 399 indexed citations
13.
Gascoyne, Randy D., Stanisław Krajewski, Maryla Krajewska, et al.. (1997). Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma. Blood. 90(1). 244–251. 26 indexed citations
14.
O’Reilly, Susan E. & Joseph M. Connors. (1993). Is There a Role for MACOP-B in the Treatment of Diffuse Large Cell Lymphoma?. Leukemia & lymphoma. 10(sup1). 85–89. 1 indexed citations
15.
O’Reilly, Susan E., Paul Hoskins, Paul Klimo, & Joseph M. Connors. (1991). MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease. Annals of Oncology. 2. 17–23. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret Shovlin Breakdown of academic impact, for papers by M. Jesús Nambo Breakdown of academic impact, for papers by Brandelyn N. Pitcher Breakdown of academic impact, for papers by Simone Ferrero Breakdown of academic impact, for papers by D.J. van Spronsen Breakdown of academic impact, for papers by Martin Bast Breakdown of academic impact, for papers by Maud Janvier Breakdown of academic impact, for papers by Jens Ersbøll Breakdown of academic impact, for papers by Virginie Lucas Breakdown of academic impact, for papers by Lucia Nogová
Rankless by CCL
2026